Andersen AR, Friberg H, Lassen NA, Kristensen K, Neirinckx RD (1987) Serial studies of cerebral blood flow using 99m-Tc-HMPAO: a comparison with 133 Xe. Nucl Med Comm 8:549–557
Google Scholar
Büll U, Stirner H, Braun H, Kreiten K, Ferbert A (1987) SPECT with 99m-Tc-HMPAO and 99m-Tc-pertechnetate to assess regional cerebral blood flow (rCBF) and blood volume (rCBV). Preliminary results in cerebrovascular disease and interictal epilepsy. Nucl Med Comm 8:519–524
Google Scholar
Costa DC, Ell PJ, Cullum ID, Jarritt PH (1986) The in-vivo distribution of 99m-Tc-HMPAO in normal man. Nucl Med Comm 7:647–658
Google Scholar
Costa DC, Jones BE, Steiner TJ, Aspey BS, Ell PJ, Cullum I, Jewkes RF (1986) Experimental studies of Tc-99m HM-PAO with an rCBF model. Nucl Med Comm 7:282–283
Google Scholar
Gruner KR (1986) Die Entwicklung heutiger Radiopharmaka aus der Sicht des Herstellers. Der Nuklearmediziner 9:297–315
Google Scholar
Kircos LT, Carey JE, Keyes JW (1987) Quantitative organ visualization using SPECT. J Nucl Med 28:334–341
Google Scholar
Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, Wu JL, Phelps ME (1982) Quantifying local cerebral blood flow by N-Isopropyl-p-123-I-Iodoamphetamine (IMP) tomography. J Nucl Med 23:196–203
Google Scholar
Larsson S (1980) Gamma camera emission tomography. Acta Radiologica Supplementum 363, Stockholm
Lassen NA, Andersen AR, Neirinckx RD, Ell PJ, Costa DC (1987) Validation of Ceretec. In: Ell PJ (ed) The clinical application of rCBF imaging by SPECT. Amersham International, Amersham, p 14
Google Scholar
Leonard J-P, Nowotnik DP, Neirinckx RD (1986) Technetium-99m-d, 1-HM-PAO: A new radiopharmaceutical for imaging regional brain perfusion using SPECT — A comparison with Iodine-123 HIPDM. J Nucl Med 27:1819–1823
Google Scholar
Meili A, Seelentag WW, Bekier A (1986) Die cerebrale 99m-Tc-Hexamethyl-Propylenaminoxim-Speicherung in Beziehung zu individuellen Faktoren wie Alter, Größe und Gewicht. Nucl Compact 17:334–336
Google Scholar
Msaki P, Axelsson B, Dahl CM, Larsson SA (1987) Generalized scatter correction method in SPECT using point scatter distribution functions. J Nucl Med 28:1861–1869
Google Scholar
Neirinckx RD (1987) Trapping mechanisms of HM-PAO. Symposium of the Rheinisch-Westfälische Gesellschaft für Nulearmedizin, Bonn
Neirinckx RD, Nowotnik DP, Pickett RD, Harrison RC, Ell PJ (1987) Development of a lipophilic 99m-Tc complex useful for brain perfusion evaluation with conventional SPECT imaging equipment. In: Biersack HJ, Winkler C (eds) Amphetamines and pH-shift agents for brain imaging: basic research and clinical results. De Gruyter, Berlin-New York, p 59
Google Scholar
Nickel O, Schad N, Andrews EJ, Fleming JW, Mello M (1982) Scintigraphic measurement of left ventricular volumes from the count-density distribution. J Nucl Med 23:404–410
Google Scholar
Nickel O, Roesler A, Eißner D, Ulrich P, Lindner P, Hahn K (1987) Erste klinische Ergebnisse zur rCBF-Quantifizierung mit 99mTc-HMPAO-SPECT. Nucl Compact 18:35–38
Google Scholar
Obrist WD, Thompson HK, King CD, Wang HS (1967) Determination of regional cerebral blood flow by inhalation of 133-Xenon. Circ Res 20:124–135
Google Scholar
Schulthess GK, Ketz E, Schubiger PA, Bekier A (1985) Regional quantitative noninvasive assessment of cerebral perfusion and function with N-Isopropyl-123-I-p-Iodoamphetamine. J Nucl Med 26:9–16
Google Scholar
Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NTS, Gvozdanovic D, Davidson J, Tyrrell DA, Pickett RD, Neirinckx RD (1986) Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: Human volunteer studies. J Nucl Med 27:171–177
Google Scholar
Sorenson JA (1974) Quantitative measurement of radioactivity in vivo by whole-body counting. In: Hine GJ, Sorenson JA (eds) Instrumentation in Nuclear Medicine, vol. 2. Academic Press, New York, pp 311–348
Google Scholar